“No Ink on Tumor” in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
Authors:
- Giulia AtzoriGAGiulia Atzori
- Marco GipponiMGMarco Gipponi
- Chiara CornacchiaCCChiara Cornacchia
- Raquel DiazRDRaquel Diaz
- Marco SparavignaMSMarco Sparavigna
- Maurizio GalloMGMaurizio Gallo
- Tommaso RuelleTRTommaso Ruelle
- Federica MurelliFMFederica Murelli
- Simonetta FranchelliSFSimonetta Franchelli
- Francesca DepaoliFDFrancesca Depaoli
- Daniele FriedmanDFDaniele Friedman
- Piero FregattiPFPiero Fregatti
Open Access
- 23 June 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1031
Abstract
Background/Aim: Patients with Stage I-II breast cancer undergoing breast-conserving surgery after neoadjuvant chemotherapy (BCS-NAC) were retrospectively assessed in order to evaluate the extent of a safe excision margin. Materials and Methods: Between 2003 and 2020, 151 patients underwent risk-adapted BCS-NAC; margin involvement was always assessed at definitive histology. Patients with complete pathological response (pCR) were classified as the RX group, whereas those with residual disease and negative margins were stratified as R0 < 1 mm (margin < 1 mm) and R0 > 1 mm (margin > 1 mm). Results: Totals of 29 (19.2%), 64 (42.4%), and 58 patients (38.4%) were included in the R0 < 1 mm, R0 > 1 mm, and RX groups, respectively, and 2 patients with margin involvement had a mastectomy. Ten instances of local recurrence (6.6%) occurred, with no statistically significant difference in local recurrence-free survival (LRFS) between the three groups. A statistically significant advantage of disease-free survival (p = 0.002) and overall survival (p = 0.010) was observed in patients with pCR. Conclusions: BCS-NAC was increased, especially in HER-2-positive and triple-negative tumors; risk-adapted BCS should be preferably pursued to highlight the cosmetic benefit of NAC. The similar rate of LRFS in the three groups of patients suggests a shift toward the “no ink on tumor” paradigm for patients undergoing BCS-NAC.Keywords
This publication has 46 references indexed in Scilit:
- Preoperative Magnetic Resonance Imaging in Breast CancerAnnals of Surgery, 2013
- The Value of Combined Large Format Histopathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Institution Study of 40 CasesInternational Journal of Breast Cancer, 2012
- Breast tattoos for planning surgery following neoadjuvant chemotherapyThe American Journal of Surgery, 2007
- Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeJournal of Surgical Oncology, 2006
- Impact of Preoperative Versus Postoperative Chemotherapy on the Extent and Number of Surgical Procedures in Patients Treated in Randomized Clinical Trials for Breast CancerAnnals of Surgery, 2006
- Patient Involvement in Surgery Treatment Decisions for Breast CancerJournal of Clinical Oncology, 2005
- Breast conservation after neoadjuvant chemotherapyCancer, 2005
- Diagnostic Approaches to the Pathology of Primary Breast Cancer Before and After Neoadjuvant ChemotherapySeminars in Breast Disease, 2004
- Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center ExperienceJournal of Clinical Oncology, 2004
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988